An Alternative Framework for Analyzing Financial Protection in Health
article has not abstract
Vyšlo v časopise:
An Alternative Framework for Analyzing Financial Protection in Health. PLoS Med 9(8): e32767. doi:10.1371/journal.pmed.1001294
Kategorie:
Policy Forum
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001294
Souhrn
article has not abstract
Zdroje
1. World Health Organization (2000) World health report: health systems: improving performance. Geneva: WHO.
2. World Health Organization (2010) World health report: health systems financing: the path to universal coverage. Geneva: WHO.
3. World Health Assembly (2011) Sustainable health financing structures and universal coverage. Resolution WHA64.9, 24 May 2011. Available: http://apps.who.int/gb/ebwha/pdf_files/WHA64/A64_R9-en.pdf. Accessed 18 January 2011.
4. Moreno-SerraR, MillettC, SmithPC (2011) Towards improved measurement of financial protection in health. PLoS Med 8 (9) e1001087 doi:10.1371/journal.pmed.1001087.
5. Wagstaff A (2008) Measuring financial protection in health. Policy research working paper 4554. Washington DC: World Bank. Available http://www-wds.worldbank.org/servlet/WDSContentServer/WDSP/IB/2008/03/12/000158349_20080312140044/Rendered/PDF/wps4554.pdf. Accessed 18 January 2011.
6. XuK, EvansDB, KawabataK, ZeramdiniR, KlavusJ, et al. (2003) Household catastrophic health expenditure: a multicountry analysis. Lancet 362 (9378) 111–117.
7. van DoorslaerE, O'DonnellO, Rannan-EliyaRP, SomanathanA, AdhikariSR, et al. (2007) Catastrophic payments for health care in Asia. Health Econ 16 (11) 1159–1184.
8. LimwattananonS, TangcharoensathienV, PrakongsaiP (2007) Catastrophic and poverty impacts of health payments: results from national household surveys in Thailand. Bull World Health Organ 85: 600–606.
9. HabichtJ, XuK, CouffinhalA, KutzinJ (2006) Detecting changes in financial protection: creating evidence for policy in Estonia. Health Policy Plan 21 (6) 421–431.
10. LiuY, RaoK, HsiaoWC (2003) Medical expenditure and rural impoverishment in China. J Health Popul Nutr 21 (3) 216–222.
11. RugerJP, KimHJ (2007) Out-of-pocket healthcare spending by the poor and chronically ill in the Republic of Korea. Am J Public Health 97: 804–811.
12. LuC, ChinB, LiG, MurrayCJL (2009) Limitations of methods for measuring out-of-pocket and catastrophic private health expenditures. Bull World Health Organ 87: 238–244.
13. SchoenC, OsbornR, SquiresD, DotyMM, PiersonR, et al. (2010) How health insurance design affects access to care and costs, by income, in eleven countries. Health Aff 29 (12) 2323–2334.
14. The Commonwealth Fund (2010) Commonwealth Fund international health policy survey. Available http://www.commonwealthfund.org/Surveys/2010/Nov/2010-International-Survey.aspx. Accessed 18 January 2011.
15. RugerJP (2003) Catastrophic health expenditure. Lancet 362 (9388) 996–997.
16. RugerJP, RichterCJ, LewisLM (2003) Association between insurance status and admission rate for patients evaluated in the emergency department. Acad Emerg Med 10 (11) 1285–1288.
17. Preker AS, Carrin G, Dror D, Jakab M, Hsiao WC et al.. (2004) Rich-poor differences in health care financing. In: Preker AS, Carrin G, editors. Health financing for poor people. Washington DC: World Bank. pp. 3–52.
18. Van DammeW, MeessenB, PorI, KoberK (2003) Catastrophic health expenditure. Lancet 362 (9388) 996.
19. RugerJP (2007) Moral foundations of health insurance. QJM 100 (1) 53–57.
20. NguyenKT, KhuatOTH, MaS, PhamDC, KhuatGTH, et al. (2012) Coping with health care expenses among poor households: evidence from a rural commune in Vietnam. Soc Sci Med 74 (5) 724–733.
21. NguyenKT, KhuatOTH, MaS, PhamDC, KhuatGTH, et al. (2012) Impact of health insurance on health care treatment and cost in Vietnam: a health capability approach to financial protection. Am J Public Health 102 (8) 1450–1461.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2012 Číslo 8
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Feasibility, Yield, and Cost of Active Tuberculosis Case Finding Linked to a Mobile HIV Service in Cape Town, South Africa: A Cross-sectional Study
- Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
- Child Mortality Estimation: A Global Overview of Infant and Child Mortality Age Patterns in Light of New Empirical Data
- What Is the Optimal First Line Antiretroviral Therapy in Resource-Limited Settings?